Skip to content
Their Record

Senate Roll Call 389, 116th Congress · December 10, 2019

A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.

Question before the chamber: On Passage of the Bill

91 yea · 2 nayBill Passed7 not voting or present
Democrat37 yea · 0 nay
Republican51 yea · 2 nay
Independent3 yea · 0 nay

Solid = yea, faded = nay.

The measure

S. 2740

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

  • Health CareDirection unreadable — not scored

    excluded:model-unclear (0.90) Regulating nonprescription OTC drugs does not alter healthcare insurance coverage.

    Tagged by: policy-area:Health

    Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.